Cancer Drug Price Cuts Must Reach Patients, Says Former National Health Authority Chief, Pg14

Key Highlights:

• The National Pharmaceutical Pricing Authority (NPPA) capped trade margins on 137 anti-cancer medicines.
• The cap is set at 30% of the Maximum Retail Price (MRP), excluding GST, effective from November 9.
• Former National Health Authority (NHA) CEO, Indu Bhushan, emphasized the need for these savings to directly benefit patients.
• A 2023 study indicated an average annual out-of-pocket expenditure of approximately ₹3.31 lakh per cancer patient in India.

Detailed Insights:

• The decision was implemented through trade margin rationalization under the Drugs (Prices Control) Order, 2013.
• This measure targets excessive mark-ups across the distribution and retail chain for identified non-scheduled anti-cancer medicines.
• Affordability remains a significant challenge, with patients incurring substantial costs beyond treatment, such as travel and lost income.
• Strategies to enhance affordability include promoting generic drugs, biosimilars, and strengthening domestic pharmaceutical manufacturing.
• For expensive patented medicines, approaches like negotiated prices and voluntary licensing are suggested to improve access.
• Financial protection in cancer care extends beyond price regulation, as demonstrated by schemes like Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (PM-JAY).
• Strategic purchasing and well-designed treatment packages are crucial to ensure quality care and prevent unnecessary procedures.
• Increased public investment in cancer prevention, early detection, and specialized treatment infrastructure is also vital.

Key Concepts Involved:

• National Pharmaceutical Pricing Authority (NPPA): A government regulatory agency that controls the prices of pharmaceutical drugs in India.
• Drugs (Prices Control) Order, 2013: A legal framework empowering the NPPA to fix and regulate the prices of essential drugs.
• Maximum Retail Price (MRP): The highest price that can be charged for a product sold in India, inclusive of all taxes.
• Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (PM-JAY): A flagship national health protection scheme providing health coverage to vulnerable families.